Trinity Biotech Plc Stock Price Prediction

TRIB Stock  USD 0.91  0.00  0.000003%   
At the present time, the relative strength index (RSI) of Trinity Biotech's share price is approaching 36. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Trinity Biotech, making its price go up or down.

Momentum 36

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Trinity Biotech's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Trinity Biotech plc, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Trinity Biotech's stock price prediction:
Quarterly Earnings Growth
(0.77)
EPS Estimate Next Quarter
(0.51)
EPS Estimate Next Year
(1.09)
Wall Street Target Price
3
EPS Estimate Current Quarter
(0.57)
Using Trinity Biotech hype-based prediction, you can estimate the value of Trinity Biotech plc from the perspective of Trinity Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Trinity Biotech using Trinity Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Trinity using crowd psychology based on the activity and movement of Trinity Biotech's stock price.

Trinity Biotech Short Interest

A significant increase or decrease in Trinity Biotech's short interest from the previous month could be a good indicator of investor sentiment towards Trinity. Short interest can provide insight into the potential direction of Trinity Biotech stock and how bullish or bearish investors feel about the market overall.
200 Day MA
0.8609
Short Percent
0.0067
Short Ratio
0.61
Shares Short Prior Month
23.1 K
50 Day MA
1.0576

Trinity Biotech plc Hype to Price Pattern

Investor biases related to Trinity Biotech's public news can be used to forecast risks associated with an investment in Trinity. The trend in average sentiment can be used to explain how an investor holding Trinity can time the market purely based on public headlines and social activities around Trinity Biotech plc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Trinity Biotech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Trinity Biotech.

Trinity Biotech Implied Volatility

    
  5.23  
Trinity Biotech's implied volatility exposes the market's sentiment of Trinity Biotech plc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trinity Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trinity Biotech stock will not fluctuate a lot when Trinity Biotech's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Trinity Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Trinity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Trinity Biotech after-hype prediction price

    
  USD 0.91  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Trinity Biotech Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.071.409.59
Details
Naive
Forecast
LowNextHigh
0.021.109.29
Details
1 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.51-0.51-0.51
Details

Trinity Biotech After-Hype Price Density Analysis

As far as predicting the price of Trinity Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Trinity Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Trinity Biotech, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Trinity Biotech Estimiated After-Hype Price Volatility

In the context of predicting Trinity Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Trinity Biotech's historical news coverage. Trinity Biotech's after-hype downside and upside margins for the prediction period are 0.05 and 9.10, respectively. We have considered Trinity Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.91
0.91
After-hype Price
9.10
Upside
Trinity Biotech is abnormally volatile at this time. Analysis and calculation of next after-hype price of Trinity Biotech plc is based on 3 months time horizon.

Trinity Biotech Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Trinity Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Trinity Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Trinity Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.16 
8.19
 0.00  
  0.01 
11 Events / Month
5 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.91
0.91
0.00 
0.00  
Notes

Trinity Biotech Hype Timeline

Trinity Biotech plc is at this time traded for 0.91. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Trinity is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.16%. %. The volatility of related hype on Trinity Biotech is about 17062.5%, with the expected price after the next announcement by competition of 0.90. About 12.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.3. Trinity Biotech plc recorded a loss per share of 1.8. The entity last dividend was issued on the 5th of June 2015. The firm had 1:5 split on the 23rd of February 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days.
Check out Trinity Biotech Basic Forecasting Models to cross-verify your projections.

Trinity Biotech Related Hype Analysis

Having access to credible news sources related to Trinity Biotech's direct competition is more important than ever and may enhance your ability to predict Trinity Biotech's future price movements. Getting to know how Trinity Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Trinity Biotech may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ADVBAdvanced Biomed Common 0.01 4 per month 0.00 (0.09) 10.00 (10.81) 39.70 
BGLCBioNexus Gene Lab 0.06 9 per month 0.00 (0.26) 4.23 (6.61) 14.16 
XAIRBeyond Air 0.01 7 per month 6.75  0.01  14.46 (11.85) 163.02 
MRKRMarker Therapeutics 0.02 8 per month 4.44  0.19  12.79 (7.04) 26.24 
CHEKCheck Cap(0.06)9 per month 6.07  0.12  17.16 (10.37) 198.26 
GBSGBS Inc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SINTSINTX Technologies(0.65)6 per month 5.37  0.03  9.09 (6.54) 32.00 
EVGNEvogene 0.01 7 per month 0.00 (0.08) 3.77 (5.22) 21.65 
SNSESensei Biotherapeutics 0.11 7 per month 5.92  0  17.33 (10.69) 36.61 
TNONTenon Medical 0.01 7 per month 0.00 (0.12) 5.98 (4.20) 16.03 

Trinity Biotech Additional Predictive Modules

Most predictive techniques to examine Trinity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Trinity using various technical indicators. When you analyze Trinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Trinity Biotech Predictive Indicators

The successful prediction of Trinity Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Trinity Biotech plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Trinity Biotech based on analysis of Trinity Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Trinity Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Trinity Biotech's related companies.
 2025 2026 (projected)
Dividend Yield0.003370.001908
Price To Sales Ratio1.481.4

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Trinity Stock analysis

When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges